Contrast agents in abdominal imaging: current and future directions.
about
Toward a standardized system for hepatocellular carcinoma diagnosis using computed tomography and MRI.Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats
P2860
Contrast agents in abdominal imaging: current and future directions.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Contrast agents in abdominal imaging: current and future directions.
@ast
Contrast agents in abdominal imaging: current and future directions.
@en
type
label
Contrast agents in abdominal imaging: current and future directions.
@ast
Contrast agents in abdominal imaging: current and future directions.
@en
prefLabel
Contrast agents in abdominal imaging: current and future directions.
@ast
Contrast agents in abdominal imaging: current and future directions.
@en
P2093
P1476
Contrast agents in abdominal imaging: current and future directions.
@en
P2093
Alexander Mamann
Giovanni Morana
Günther Schneider
Luigi Grazioli
Miles A Kirchin
Peter Reimer
P304
P356
10.1097/01.RMR.0000189025.80743.5C
P577
2005-02-01T00:00:00Z